Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.

Velliquette RA, Kossover R, Previs SF, Ernsberger P.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):300-12. Epub 2006 Jan 17.

PMID:
16416266
2.
3.
5.
6.

The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Ernsberger P, Friedman JE, Koletsky RJ.

J Hypertens Suppl. 1997 Jan;15(1):S9-23. Review.

7.

Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.

Bock C, Niederhoffer N, Szabo B.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Apr;359(4):262-71.

PMID:
10344524
8.

Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.

Mukaddam-Daher S, Menaouar A, Gutkowska J.

Eur J Pharmacol. 2006 Jul 10;541(1-2):73-9. Epub 2006 May 12.

PMID:
16774751
9.

Pharmacology of moxonidine, an I1-imidazoline receptor agonist.

Ziegler D, Haxhiu MA, Kaan EC, Papp JG, Ernsberger P.

J Cardiovasc Pharmacol. 1996;27 Suppl 3:S26-37. Review.

PMID:
8872297
10.

Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.

Haxhiu MA, Dreshaj I, Schäfer SG, Ernsberger P.

J Cardiovasc Pharmacol. 1994;24 Suppl 1:S1-8.

PMID:
7533221
11.
12.

Contrasting metabolic effects of antihypertensive agents.

Velliquette RA, Ernsberger P.

J Pharmacol Exp Ther. 2003 Dec;307(3):1104-11. Epub 2003 Oct 13.

PMID:
14557373
13.

A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Ernsberger P, Haxhiu MA, Graff LM, Collins LA, Dreshaj I, Grove DL, Graves ME, Schäfer SG, Christen MO.

Cardiovasc Drugs Ther. 1994 Mar;8 Suppl 1:27-41.

PMID:
8068578
14.

Why imidazoline receptor modulator in the treatment of hypertension?

Schäfer SG, Kaan EC, Christen MO, Löw-Kröger A, Mest HJ, Molderings GJ.

Ann N Y Acad Sci. 1995 Jul 12;763:659-72. Review.

PMID:
7677385
15.
17.

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.

Cao C, Kang CW, Kim SZ, Kim SH.

Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H150-6. Epub 2004 Feb 19.

20.

Supplemental Content

Support Center